JP Morgan Call 480 GOS 21.06.2024/ DE000JQ5A6U1 /
06/06/2024 08:37:51 | Chg.+0.003 | Bid09:59:22 | Ask09:59:22 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.015EUR | +25.00% | 0.015 Bid Size: 20,000 |
0.025 Ask Size: 20,000 |
GOLDMAN SACHS GRP IN... | 480.00 - | 21/06/2024 | Call |
GlobeNewswire
01:53
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
GlobeNewswire
05/06
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
Sterling Check Corp. Investigated by Block & Leviton; Investors Are Encouraged to Contact the Firm
GlobeNewswire
05/06
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
05/06
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
05/06
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare C...
GlobeNewswire
05/06
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05/06
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
09/05
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
11/04
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties